Last edited by Vuzahn
Thursday, August 6, 2020 | History

2 edition of inhibition of elongation factor Tu by kirromycin. found in the catalog.

inhibition of elongation factor Tu by kirromycin.

David John Brockwell

inhibition of elongation factor Tu by kirromycin.

by David John Brockwell

  • 299 Want to read
  • 17 Currently reading

Published by UniversityofManchester in Manchester .
Written in English


Edition Notes

Thesis (Ph.D.), - University of Manchester, Department of Pharmacy.

ContributionsUniversity of Manchester. Department of Pharmacy.
The Physical Object
Pagination218p.
Number of Pages218
ID Numbers
Open LibraryOL22261571M

Six kirromycin analogs (elfamycins) were compared on the basis of their inhibition of Escherichia coli poly(U)-directed poly(Phe) synthesis and stimulation of elongation factor Tu (EF-Tu)-associated GTPase activity. The elfamycins tested were kirromycin, aurodox, efrotomycin, phenelfamycin A, unphenelfamycin, and L, Sep 25,  · The binding of aminoacyl-transfer RNA to the ribosome is catalysed by the elongation factor Tu (EF-Tu). kirromycin, and finally the EF-Tu inhibition of protein synthesis by kirromycin. Cited by:

EF-Tu,elongationfactorT(EF-T),EF-G,andNH4Cl-washed ribosomes were isolated from Escherichia coli D (9, 10). Kirromycin-resistant EF-Tufor experimentsshownin Fig. 1 was isolated from E. coli D as described (9, 10). The elongation factor-containing fractions were >90% pure as judged by sodium dodecyl sulfate gel electrophoresis. One. Kirromycin, an inhibitor of the protein biosynthesis that acts on elongation factor Tu: H. Wolf, et al.; PNAS 71, () Mechanism of the inhibition of protein synthesis by kirromycin. Role of elongation factor Tu and ribosomes: H. Wolf, et al.; Eur. J. Biochem.

The polyenic antibiotic kirromycin inhibits the translational elongation factor, EF-Tu, blocking its exit from the ribosome. Kirromycin-resistant alleles of the tuf genes, which encode EF-Tu, have been isolated. Abstract. EF-Tu fromE. coli, one of the superfamily of GTPase switch proteins, plays a central role in the fast and accurate delivery of aminoacyl-tRNAs to the translating carthage-publicite.com overview is given about the regulatory effects of methylation, phosphorlation and phage-induced cleavage of EF-Tu on its carthage-publicite.com by:


Share this book
You might also like
ALAIN MANOUKIAN SA

ALAIN MANOUKIAN SA

Insight Guides Dresden

Insight Guides Dresden

Pan Africanism

Pan Africanism

Industrial relations in India

Industrial relations in India

work of Szukalski.

work of Szukalski.

Employers guide to military leave compliance

Employers guide to military leave compliance

Energy efficiency report.

Energy efficiency report.

Pulpwood prices in the Southeast, 1974

Pulpwood prices in the Southeast, 1974

Figures

Figures

Renascence

Renascence

work of Frank Lloyd Wright from 1893 to 1900

work of Frank Lloyd Wright from 1893 to 1900

Inhibition of elongation factor Tu by kirromycin by David John Brockwell Download PDF EPUB FB2

May 01,  · MDL 62, (formerly GE A) is a novel antibiotic active against Gram-positive bacteria by inhibiting protein synthesis. MDL 62, is not active against Gram-negative bacteria, but inhibits cell-free protein synthesis in extracts from Escherichia coli, and shows a high binding affinity for its elongation factor Tu (EF-Tu).

Summary This chapter contains sections titled: Introduction Enacyloxins Kirromycin Pulvomycin GEA References Inhibitors of Bacterial Elongation Factor EF‐Tu - Antibiotics - Wiley Online Library Skip to Article ContentAuthor: Attilio Fabbretti, Anna Maria Giuliodori.

Kirromycin, for example, was used in a study of the interaction between EF-Tu and MreB, a protein that impacts cell shape (Defeu Soufo et al., ); this study determined that EF-Tu also impacts cell shape, with kirromycin being used to determine that EF-Tu activity in translation is independent from colocalization activity with MreB.

Thus, elfamycins are not only useful in the context of new antibiotics Cited by: The binding of the antibiotic kirromycin (mocimycin) to its target protein, bacterial elongation factor Tu (EF-Tu), has been studied by 1H NMR spectroscopy using deuterated protein.

Request PDF | Inhibitors of Bacterial Elongation Factor EF-Tu | Introduction Enacyloxins Kirromycin Pulvomycin GEA References | Find, read and cite all the research you need on ResearchGate.

attempt to localize the site of this inhibition, we have ex-amined the action of this antibiotic on the partial steps of polypeptide chain elongation. Ourresults showthat kirromy-cim inhibits the peptidyl transfer reaction inhibition of elongation factor Tu by kirromycin.

book acting on the elongation factor Tu (EF-Tu) and is thus the first antibiotic found to haveEF-Tuas its target. Kirromycinhas proved toCited by: The antibiotic kirromycin inhibits prokaryotic protein synthesis by immobilizing elongation factor Tu (EF-Tu) on the elongating ribosome.

Streptomyces ramocissimus, the producer of kirromycin, contains three tuf carthage-publicite.com by: Mechanism of the Inhibition of Protein Synthesis by Kirromycin Role of Elongation Factor Tu and Ribosomes.

Heinz WOLF 1, Gianni CHINALI 2 and; Andrea PARMEGGIANI 3,* Article first published online: 28 JUN DOI: /jtbx. Eur. Biochem. 75, () Mechanism of the Inhibition of Protein Synthesis by Kirromycin Role of Elongation Factor Tu and Ribosomes Heinz WOLF, Gianni CHINALI, and Andrea PARMEGGIANI Abteilung Biochemie, Cresellschaft for Molekularbiologische Forschung, Braunschweig-Stockheim,Cited by: Kirromycin, a new inhibitor of protein synthesis, is shown to interfere with the peptide transfer reaction by acting on elongation factor Tu (EF-Tu).

All the reactions associated with this elongation factor are affected. Formation of the EF-Tu·GTP complex is strongly carthage-publicite.com by: We have investigated the mechanism which allows the antibiotic kirromycin to inhibit peptide bond formation by acting on elongation factor Tu (EF‐Tu).

Gel filtration experiments show that with kirromycin after enzymic binding of aminoacyl‐tRNA to ribosomes and subsequent GTP hydrolysis EF‐Tu is not released from the carthage-publicite.com by: There are only three kinds of antibiotics whose target is not the ribosome, but an elongation factor.

The antibiotic fusidic acid inhibits the translocation reaction catalyzed by the elongation factor G (EF-G). The antibiotics kirromycin and pulvomycin inhibit the substrate supply by acting on the elongation factor Tu (EF-Tu); however, Cited by: 1.

The activity of elongation factor Tu (EF-Tu) from Escherichia coli in eucaryotic protein synthesis systems was investigated. EF-Tu was found to inhibit polyphenylalanine synthesis when incubated with Artemia 80S ribosomes, purified rabbit reticulocyte elongation factor Tu (eEF-Tu) and partially purified reticulocyte translocase enzyme, eEF-G.

The inhibition could be overcome by supplying the Cited by: 6. Pulvomycin and the synonymous antibiotics labilomycin and Z are shown to inhibit prokaryotic protein synthesis by acting on elongation factor Tu (EF-Tu): in the presence of the antibiotic, the affinity of EF-Tu for guanine nucleotides is altered, the carthage-publicite.com exchange is catalyzed, and the formation of the carthage-publicite.com complex is carthage-publicite.com by: Kirromycin, a new inhibitor of protein synthesis, is shown to interfere with the peptide transfer reaction by acting on elongation factor Tu (EF-Tu).

All the reactions associated with this elongation factor are affected. Formation of the carthage-publicite.com complex is strongly stimulated. elongation factor Tu (EF-Tu), and are defined by their target, rather than a conserved structure.

With development of resistance to other classic antibiotics, interest has renewed in inhibitors of EF-Tu. EF-Tu GTPase activity EF-Tu belongs to the G protein family, a collection of. Elongation factor Tu (EF-Tu) is encoded by the tuf gene of the plastid organelle of the malaria parasite Plasmodium falciparum.A range of structurally unrelated inhibitors of this GTP-dependent translation factor was shown to have antimalarial activity in blood carthage-publicite.com by: Kirromycin.

The polyenic antibiotic kirromycin inhibits the translational elongation factor, EF-Tu, blocking its exit from the ribosome. Kirromycin-resistant alleles of the tuf genes, which encode EF-Tu, have been isolated. Individually, these mutations lead to amino acid substitutions at.

Antibiotic MDL 62, inhibits bacterial protein synthesis by acting on elongation factor Tu (EF-Tu). In this study we show that the inhibition of protein synthesis by MDL 62, in an Escherichia coli cell-free system was fully reversed by addition of stoichiometric amounts of EF-Tu but not by large excesses of EF-Ts, ribosomes, or carthage-publicite.com by: EF-Tu (elongation factor thermo unstable) is a prokaryotic elongation factor responsible for catalyzing the binding of an aminoacyl-tRNA (aa-tRNA) to the ribosome.

It is a G-protein, and facilitates the selection and binding of an aa-tRNA to the A-site of the carthage-publicite.comro: IPR. Elongation factor Tu (EF-Tu) dependent GTP hydrolysis normally requires the presence of ribosomes and aminoacyl-tRNA (aa-tRNA).

In the presence of the antibiotic kirromycin, the factor alone displays a GTPase activity that is enhanced by ribosomes and/or aa-tRNA [Wolf, H., Chinali, G., & Parmeggiani, A. () Proc. Natl. Acad. Sci. U.S.A. 71, ].Wolf H, Chinali G, Parmeggiani A. Kirromycin, an inhibitor of protein biosynthesis that acts on elongation factor Tu.

Proc Natl Acad Sci U S A. Dec; 71 (12)– [PMC free article] Wolf H, Chinali G, Parmeggiani A. Mechanism of the inhibition of protein synthesis by kirromycin. Role of elongation factor Tu and ribosomes.MicrObiology (1 ),Printed in Great Britain Natural kirromycin resistance of elongation factor Tu from the kirrothricin producer Streptomyces cinnamoneus Carmela Cappellano.